Back to Search
Start Over
LO4 : A phase 2, randomized, placebo-controlled study (IMAGO) of LUM001, a novel inhibitor of the apical sodium-dependent bile acid transporter (ASBT), in paediatric patients with alagille syndrome (ALGS).
LO4 : A phase 2, randomized, placebo-controlled study (IMAGO) of LUM001, a novel inhibitor of the apical sodium-dependent bile acid transporter (ASBT), in paediatric patients with alagille syndrome (ALGS).
- Source :
-
Journal of Hepatology . Apr2015 Supplement 2, Vol. 62, pS259-S259. 1p. - Publication Year :
- 2015
Details
- Language :
- English
- ISSN :
- 01688278
- Volume :
- 62
- Database :
- Academic Search Index
- Journal :
- Journal of Hepatology
- Publication Type :
- Academic Journal
- Accession number :
- 103201886
- Full Text :
- https://doi.org/10.1016/S0168-8278(15)30150-1